Dataset Information


Proteomic response of S. aureus with entrectinib treatment

ABSTRACT: S. aureus isolate was inoculated and cultured to exponential growth phase (OD600 at 0.5) in TSB and divided into two groups, the control group and the drug treated group. Entrectinib was added to the drug treated group until a final concentration of 1/2× MIC reached, and DMSO added in the control group. Then, cultures in both groups were cultivated for 2 h at 200 rpm. The microbial was centrifuged at 12000 rpm for 10 min, washed twice with Phosphate Buffer Saline (PBS). Lyse the cells by bead-beating at 4 °C in RIPA lysis buffer (1% Triton X-100, 1% deoxycholate, 0.1% SDS), The protein reduction, alkylation and tryptic digestion were followed as filter-aided sample preparation (FASP). The digestion products were analyzed with liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS), followed by label-free quantitative analysis. The MS experiment was performed on a Q Exactive plus mass spectrometer.

ORGANISM(S): Staphylococcus Aureus

SUBMITTER: Zhijian Yu  

PROVIDER: PXD038342 | iProX | Wed Nov 23 00:00:00 GMT 2022


altmetric image


Inhibition of planktonic growth and biofilm formation of <i>Staphylococcus aureus</i> by entrectinib through disrupting the cell membrane.

Liu Shanghong S   Xiong Yanpeng Y   Xiao Haitao H   Zheng Jinxin J   Wen Zewen Z   Li Duoyun D   Deng Qiwen Q   Yu Zhijian Z  

Frontiers in microbiology 20230109

Over the last few decades, <i>Staphylococcus aureus</i> infection remain a major medical challenge and health concern worldwide. Biofilm formation and antibiotic resistance caused by <i>S. aureus</i> make it difficult to be eradicated from bacterial infections in clinics. In this study, our data demonstrated the antibacterial and excellent anti-biofilm activity of entrectinib against <i>S. aureus</i>. Entrectinib also exhibited the good safety, suggesting no toxicity with antibacterial concentra  ...[more]

Similar Datasets

2022-11-25 | PXD038354 | iProX
2023-01-12 | PXD039378 | iProX
| S-EPMC8116160 | BioStudies
2022-10-17 | PXD037518 | iProX
2022-07-14 | PXD035364 | iProX
2003-12-14 | GSE405 | GEO
| S-EPMC3635492 | BioStudies
| S-EPMC2989539 | BioStudies
| S-EPMC8222334 | BioStudies
| S-EPMC7947126 | BioStudies